nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—ABCB1—ovarian cancer	0.215	1	CbGaD
Amiodarone—CYP3A7—Paclitaxel—ovarian cancer	0.0355	0.0883	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0355	0.0883	CbGbCtD
Amiodarone—ABCB1—Topotecan—ovarian cancer	0.035	0.0871	CbGbCtD
Amiodarone—CYP3A5—Paclitaxel—ovarian cancer	0.0266	0.0663	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0257	0.0639	CbGbCtD
Amiodarone—CYP3A7—Docetaxel—ovarian cancer	0.0257	0.0639	CbGbCtD
Amiodarone—CYP2C8—Paclitaxel—ovarian cancer	0.0256	0.0637	CbGbCtD
Amiodarone—ABCB1—Vinorelbine—ovarian cancer	0.0247	0.0614	CbGbCtD
Amiodarone—CYP2D6—Vinorelbine—ovarian cancer	0.0232	0.0578	CbGbCtD
Amiodarone—CYP3A4—Topotecan—ovarian cancer	0.021	0.0522	CbGbCtD
Amiodarone—CYP3A5—Docetaxel—ovarian cancer	0.0192	0.0479	CbGbCtD
Amiodarone—CYP2C9—Paclitaxel—ovarian cancer	0.0179	0.0444	CbGbCtD
Amiodarone—ABCB1—Paclitaxel—ovarian cancer	0.0173	0.0431	CbGbCtD
Amiodarone—CYP3A4—Vinorelbine—ovarian cancer	0.0148	0.0368	CbGbCtD
Amiodarone—ABCB1—Docetaxel—ovarian cancer	0.0125	0.0312	CbGbCtD
Amiodarone—CYP3A4—Paclitaxel—ovarian cancer	0.0104	0.0258	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—ovarian cancer	0.00934	0.0232	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—ovarian cancer	0.0088	0.0219	CbGbCtD
Amiodarone—CYP3A4—Docetaxel—ovarian cancer	0.0075	0.0187	CbGbCtD
Amiodarone—Lucanthone—TOP1—ovarian cancer	0.00678	0.947	CrCbGaD
Amiodarone—CYP3A4—Doxorubicin—ovarian cancer	0.00559	0.0139	CbGbCtD
Amiodarone—EBP—uterine cervix—ovarian cancer	0.0038	0.054	CbGeAlD
Amiodarone—EBP—uterus—ovarian cancer	0.00316	0.045	CbGeAlD
Amiodarone—EBP—female reproductive system—ovarian cancer	0.00285	0.0404	CbGeAlD
Amiodarone—CACNA1H—myometrium—ovarian cancer	0.00231	0.0328	CbGeAlD
Amiodarone—THRB—gonad—ovarian cancer	0.00188	0.0267	CbGeAlD
Amiodarone—THRA—gonad—ovarian cancer	0.00188	0.0267	CbGeAlD
Amiodarone—THRB—female reproductive system—ovarian cancer	0.00168	0.0238	CbGeAlD
Amiodarone—THRA—female reproductive system—ovarian cancer	0.00168	0.0238	CbGeAlD
Amiodarone—THRB—female gonad—ovarian cancer	0.00153	0.0217	CbGeAlD
Amiodarone—THRA—female gonad—ovarian cancer	0.00153	0.0217	CbGeAlD
Amiodarone—THRB—vagina—ovarian cancer	0.00152	0.0216	CbGeAlD
Amiodarone—CACNA1H—gonad—ovarian cancer	0.00151	0.0214	CbGeAlD
Amiodarone—CACNA2D2—vagina—ovarian cancer	0.0015	0.0213	CbGeAlD
Amiodarone—CACNA1H—uterus—ovarian cancer	0.0015	0.0213	CbGeAlD
Amiodarone—THRA—testis—ovarian cancer	0.00135	0.0192	CbGeAlD
Amiodarone—THRB—testis—ovarian cancer	0.00135	0.0192	CbGeAlD
Amiodarone—CACNA1H—female reproductive system—ovarian cancer	0.00135	0.0191	CbGeAlD
Amiodarone—CACNA2D2—testis—ovarian cancer	0.00134	0.019	CbGeAlD
Amiodarone—SIGMAR1—myometrium—ovarian cancer	0.00132	0.0187	CbGeAlD
Amiodarone—CACNA1H—female gonad—ovarian cancer	0.00122	0.0174	CbGeAlD
Amiodarone—CACNA1H—testis—ovarian cancer	0.00109	0.0154	CbGeAlD
Amiodarone—KCNH2—myometrium—ovarian cancer	0.00105	0.0149	CbGeAlD
Amiodarone—SIGMAR1—uterine cervix—ovarian cancer	0.00102	0.0146	CbGeAlD
Amiodarone—THRA—lymph node—ovarian cancer	0.000981	0.0139	CbGeAlD
Amiodarone—THRB—lymph node—ovarian cancer	0.000981	0.0139	CbGeAlD
Amiodarone—SIGMAR1—decidua—ovarian cancer	0.000976	0.0139	CbGeAlD
Amiodarone—CACNA2D2—lymph node—ovarian cancer	0.000971	0.0138	CbGeAlD
Amiodarone—SIGMAR1—endometrium—ovarian cancer	0.000927	0.0132	CbGeAlD
Amiodarone—CYP2A6—vagina—ovarian cancer	0.000901	0.0128	CbGeAlD
Amiodarone—SIGMAR1—uterus—ovarian cancer	0.000854	0.0121	CbGeAlD
Amiodarone—KCNH2—uterine cervix—ovarian cancer	0.000815	0.0116	CbGeAlD
Amiodarone—ADRB1—female reproductive system—ovarian cancer	0.0008	0.0114	CbGeAlD
Amiodarone—CACNA1H—lymph node—ovarian cancer	0.000787	0.0112	CbGeAlD
Amiodarone—KCNH2—endometrium—ovarian cancer	0.000738	0.0105	CbGeAlD
Amiodarone—SIGMAR1—bone marrow—ovarian cancer	0.000725	0.0103	CbGeAlD
Amiodarone—SIGMAR1—female gonad—ovarian cancer	0.000698	0.00993	CbGeAlD
Amiodarone—CYP1A1—epithelium—ovarian cancer	0.000695	0.00987	CbGeAlD
Amiodarone—SIGMAR1—vagina—ovarian cancer	0.000694	0.00987	CbGeAlD
Amiodarone—CYP1A1—uterine cervix—ovarian cancer	0.000689	0.00979	CbGeAlD
Amiodarone—KCNH2—uterus—ovarian cancer	0.00068	0.00966	CbGeAlD
Amiodarone—CYP2C8—endometrium—ovarian cancer	0.000675	0.00959	CbGeAlD
Amiodarone—CYP3A5—uterine cervix—ovarian cancer	0.000673	0.00957	CbGeAlD
Amiodarone—SIGMAR1—testis—ovarian cancer	0.000619	0.00881	CbGeAlD
Amiodarone—KCNH2—female reproductive system—ovarian cancer	0.000611	0.00868	CbGeAlD
Amiodarone—CYP2C19—vagina—ovarian cancer	0.000579	0.00823	CbGeAlD
Amiodarone—KCNH2—bone marrow—ovarian cancer	0.000577	0.0082	CbGeAlD
Amiodarone—CYP1A1—uterus—ovarian cancer	0.000574	0.00816	CbGeAlD
Amiodarone—CYP2C8—female reproductive system—ovarian cancer	0.000559	0.00795	CbGeAlD
Amiodarone—KCNH2—female gonad—ovarian cancer	0.000556	0.0079	CbGeAlD
Amiodarone—KCNH2—vagina—ovarian cancer	0.000553	0.00785	CbGeAlD
Amiodarone—CYP1A1—female reproductive system—ovarian cancer	0.000516	0.00733	CbGeAlD
Amiodarone—CYP2C8—vagina—ovarian cancer	0.000506	0.00719	CbGeAlD
Amiodarone—CYP2C9—female reproductive system—ovarian cancer	0.000497	0.00706	CbGeAlD
Amiodarone—KCNH2—testis—ovarian cancer	0.000493	0.00701	CbGeAlD
Amiodarone—CYP1A1—female gonad—ovarian cancer	0.000469	0.00667	CbGeAlD
Amiodarone—CYP1A1—vagina—ovarian cancer	0.000467	0.00663	CbGeAlD
Amiodarone—ABCB1—myometrium—ovarian cancer	0.00046	0.00653	CbGeAlD
Amiodarone—CYP3A5—female gonad—ovarian cancer	0.000459	0.00653	CbGeAlD
Amiodarone—CYP3A5—vagina—ovarian cancer	0.000456	0.00649	CbGeAlD
Amiodarone—CYP2C8—testis—ovarian cancer	0.000451	0.00641	CbGeAlD
Amiodarone—SIGMAR1—lymph node—ovarian cancer	0.000449	0.00638	CbGeAlD
Amiodarone—ABCB1—embryo—ovarian cancer	0.000442	0.00628	CbGeAlD
Amiodarone—Dronedarone—ABCB1—ovarian cancer	0.000382	0.0534	CrCbGaD
Amiodarone—CYP3A4—female reproductive system—ovarian cancer	0.000379	0.00538	CbGeAlD
Amiodarone—CYP2D6—female reproductive system—ovarian cancer	0.000373	0.0053	CbGeAlD
Amiodarone—ABCB1—epithelium—ovarian cancer	0.000361	0.00513	CbGeAlD
Amiodarone—ABCB1—uterine cervix—ovarian cancer	0.000358	0.00508	CbGeAlD
Amiodarone—KCNH2—lymph node—ovarian cancer	0.000357	0.00508	CbGeAlD
Amiodarone—ABCB1—decidua—ovarian cancer	0.000341	0.00484	CbGeAlD
Amiodarone—CYP2D6—female gonad—ovarian cancer	0.000339	0.00482	CbGeAlD
Amiodarone—ABCB1—endometrium—ovarian cancer	0.000324	0.0046	CbGeAlD
Amiodarone—CYP1A1—lymph node—ovarian cancer	0.000302	0.00429	CbGeAlD
Amiodarone—CYP2D6—testis—ovarian cancer	0.000301	0.00427	CbGeAlD
Amiodarone—ABCB1—gonad—ovarian cancer	0.0003	0.00427	CbGeAlD
Amiodarone—ABCB1—uterus—ovarian cancer	0.000298	0.00424	CbGeAlD
Amiodarone—ABCB1—female reproductive system—ovarian cancer	0.000268	0.00381	CbGeAlD
Amiodarone—ABCB1—bone marrow—ovarian cancer	0.000253	0.0036	CbGeAlD
Amiodarone—ABCB1—female gonad—ovarian cancer	0.000244	0.00347	CbGeAlD
Amiodarone—ABCB1—vagina—ovarian cancer	0.000242	0.00345	CbGeAlD
Amiodarone—ABCB1—testis—ovarian cancer	0.000216	0.00307	CbGeAlD
Amiodarone—Rash—Topotecan—ovarian cancer	0.000175	0.000733	CcSEcCtD
Amiodarone—Hypersensitivity—Vinorelbine—ovarian cancer	0.000175	0.000733	CcSEcCtD
Amiodarone—Dermatitis—Topotecan—ovarian cancer	0.000175	0.000733	CcSEcCtD
Amiodarone—Ataxia—Epirubicin—ovarian cancer	0.000175	0.000732	CcSEcCtD
Amiodarone—Headache—Topotecan—ovarian cancer	0.000174	0.000729	CcSEcCtD
Amiodarone—Vomiting—Melphalan—ovarian cancer	0.000173	0.000724	CcSEcCtD
Amiodarone—Liver function test abnormal—Epirubicin—ovarian cancer	0.000172	0.000719	CcSEcCtD
Amiodarone—Rash—Melphalan—ovarian cancer	0.000172	0.000718	CcSEcCtD
Amiodarone—Dermatitis—Melphalan—ovarian cancer	0.000172	0.000717	CcSEcCtD
Amiodarone—Cough—Paclitaxel—ovarian cancer	0.000171	0.000715	CcSEcCtD
Amiodarone—Asthenia—Vinorelbine—ovarian cancer	0.000171	0.000714	CcSEcCtD
Amiodarone—Arrhythmia—Docetaxel—ovarian cancer	0.000171	0.000713	CcSEcCtD
Amiodarone—Alopecia—Docetaxel—ovarian cancer	0.000169	0.000705	CcSEcCtD
Amiodarone—Pruritus—Vinorelbine—ovarian cancer	0.000168	0.000704	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000168	0.000701	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000168	0.000701	CcSEcCtD
Amiodarone—Anxiety—Paclitaxel—ovarian cancer	0.000166	0.000696	CcSEcCtD
Amiodarone—Erythema—Docetaxel—ovarian cancer	0.000166	0.000695	CcSEcCtD
Amiodarone—Nausea—Topotecan—ovarian cancer	0.000165	0.000691	CcSEcCtD
Amiodarone—Discomfort—Paclitaxel—ovarian cancer	0.000165	0.00069	CcSEcCtD
Amiodarone—Muscular weakness—Epirubicin—ovarian cancer	0.000164	0.000687	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000164	0.000687	CcSEcCtD
Amiodarone—Cardiac arrest—Doxorubicin—ovarian cancer	0.000164	0.000685	CcSEcCtD
Amiodarone—Dry mouth—Paclitaxel—ovarian cancer	0.000163	0.000683	CcSEcCtD
Amiodarone—Diarrhoea—Vinorelbine—ovarian cancer	0.000163	0.000681	CcSEcCtD
Amiodarone—Dysgeusia—Docetaxel—ovarian cancer	0.000163	0.000681	CcSEcCtD
Amiodarone—Ataxia—Doxorubicin—ovarian cancer	0.000162	0.000677	CcSEcCtD
Amiodarone—Nausea—Melphalan—ovarian cancer	0.000162	0.000676	CcSEcCtD
Amiodarone—Confusional state—Paclitaxel—ovarian cancer	0.000161	0.000675	CcSEcCtD
Amiodarone—Back pain—Docetaxel—ovarian cancer	0.000161	0.000672	CcSEcCtD
Amiodarone—Oedema—Paclitaxel—ovarian cancer	0.00016	0.000669	CcSEcCtD
Amiodarone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00016	0.000669	CcSEcCtD
Amiodarone—Eosinophilia—Epirubicin—ovarian cancer	0.000159	0.000666	CcSEcCtD
Amiodarone—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000159	0.000665	CcSEcCtD
Amiodarone—Infection—Paclitaxel—ovarian cancer	0.000159	0.000665	CcSEcCtD
Amiodarone—Pancreatitis—Epirubicin—ovarian cancer	0.000158	0.00066	CcSEcCtD
Amiodarone—Shock—Paclitaxel—ovarian cancer	0.000158	0.000658	CcSEcCtD
Amiodarone—Dizziness—Vinorelbine—ovarian cancer	0.000157	0.000658	CcSEcCtD
Amiodarone—Angina pectoris—Epirubicin—ovarian cancer	0.000157	0.000655	CcSEcCtD
Amiodarone—ABCB1—lymph node—ovarian cancer	0.000157	0.00223	CbGeAlD
Amiodarone—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000157	0.000655	CcSEcCtD
Amiodarone—Tachycardia—Paclitaxel—ovarian cancer	0.000156	0.000653	CcSEcCtD
Amiodarone—Skin disorder—Paclitaxel—ovarian cancer	0.000156	0.00065	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000155	0.000649	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000155	0.000649	CcSEcCtD
Amiodarone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000155	0.000647	CcSEcCtD
Amiodarone—Pancytopenia—Epirubicin—ovarian cancer	0.000153	0.000639	CcSEcCtD
Amiodarone—Anorexia—Paclitaxel—ovarian cancer	0.000153	0.000638	CcSEcCtD
Amiodarone—Muscular weakness—Doxorubicin—ovarian cancer	0.000152	0.000635	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000152	0.000635	CcSEcCtD
Amiodarone—Vomiting—Vinorelbine—ovarian cancer	0.000151	0.000633	CcSEcCtD
Amiodarone—Neutropenia—Epirubicin—ovarian cancer	0.000151	0.000629	CcSEcCtD
Amiodarone—Rash—Vinorelbine—ovarian cancer	0.00015	0.000627	CcSEcCtD
Amiodarone—Dermatitis—Vinorelbine—ovarian cancer	0.00015	0.000627	CcSEcCtD
Amiodarone—Hypotension—Paclitaxel—ovarian cancer	0.00015	0.000625	CcSEcCtD
Amiodarone—Headache—Vinorelbine—ovarian cancer	0.000149	0.000623	CcSEcCtD
Amiodarone—Eosinophilia—Doxorubicin—ovarian cancer	0.000147	0.000616	CcSEcCtD
Amiodarone—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000147	0.000614	CcSEcCtD
Amiodarone—Weight increased—Epirubicin—ovarian cancer	0.000146	0.000612	CcSEcCtD
Amiodarone—Pancreatitis—Doxorubicin—ovarian cancer	0.000146	0.00061	CcSEcCtD
Amiodarone—Weight decreased—Epirubicin—ovarian cancer	0.000146	0.000609	CcSEcCtD
Amiodarone—Cough—Docetaxel—ovarian cancer	0.000145	0.000606	CcSEcCtD
Amiodarone—Angina pectoris—Doxorubicin—ovarian cancer	0.000145	0.000606	CcSEcCtD
Amiodarone—Insomnia—Paclitaxel—ovarian cancer	0.000145	0.000605	CcSEcCtD
Amiodarone—Pneumonia—Epirubicin—ovarian cancer	0.000144	0.000603	CcSEcCtD
Amiodarone—Paraesthesia—Paclitaxel—ovarian cancer	0.000144	0.000601	CcSEcCtD
Amiodarone—Dyspnoea—Paclitaxel—ovarian cancer	0.000143	0.000597	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000142	0.000595	CcSEcCtD
Amiodarone—Pancytopenia—Doxorubicin—ovarian cancer	0.000141	0.000591	CcSEcCtD
Amiodarone—Nausea—Vinorelbine—ovarian cancer	0.000141	0.000591	CcSEcCtD
Amiodarone—Renal failure—Epirubicin—ovarian cancer	0.000141	0.00059	CcSEcCtD
Amiodarone—Dyspepsia—Paclitaxel—ovarian cancer	0.000141	0.000589	CcSEcCtD
Amiodarone—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000141	0.000588	CcSEcCtD
Amiodarone—Jaundice—Epirubicin—ovarian cancer	0.00014	0.000585	CcSEcCtD
Amiodarone—Neutropenia—Doxorubicin—ovarian cancer	0.000139	0.000582	CcSEcCtD
Amiodarone—Decreased appetite—Paclitaxel—ovarian cancer	0.000139	0.000582	CcSEcCtD
Amiodarone—Dry mouth—Docetaxel—ovarian cancer	0.000138	0.000579	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000138	0.000578	CcSEcCtD
Amiodarone—Fatigue—Paclitaxel—ovarian cancer	0.000138	0.000577	CcSEcCtD
Amiodarone—Sweating—Epirubicin—ovarian cancer	0.000138	0.000575	CcSEcCtD
Amiodarone—Pain—Paclitaxel—ovarian cancer	0.000137	0.000572	CcSEcCtD
Amiodarone—Constipation—Paclitaxel—ovarian cancer	0.000137	0.000572	CcSEcCtD
Amiodarone—Confusional state—Docetaxel—ovarian cancer	0.000137	0.000572	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000136	0.000568	CcSEcCtD
Amiodarone—Anaphylactic shock—Docetaxel—ovarian cancer	0.000136	0.000567	CcSEcCtD
Amiodarone—Oedema—Docetaxel—ovarian cancer	0.000136	0.000567	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—ovarian cancer	0.000136	0.000567	CcSEcCtD
Amiodarone—Infection—Docetaxel—ovarian cancer	0.000135	0.000563	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—ovarian cancer	0.000135	0.000563	CcSEcCtD
Amiodarone—Agranulocytosis—Epirubicin—ovarian cancer	0.000134	0.00056	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—ovarian cancer	0.000134	0.000558	CcSEcCtD
Amiodarone—Shock—Docetaxel—ovarian cancer	0.000134	0.000558	CcSEcCtD
Amiodarone—Thrombocytopenia—Docetaxel—ovarian cancer	0.000133	0.000555	CcSEcCtD
Amiodarone—Tachycardia—Docetaxel—ovarian cancer	0.000132	0.000554	CcSEcCtD
Amiodarone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000132	0.000551	CcSEcCtD
Amiodarone—Skin disorder—Docetaxel—ovarian cancer	0.000132	0.000551	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000132	0.00055	CcSEcCtD
Amiodarone—Bradycardia—Epirubicin—ovarian cancer	0.000131	0.000548	CcSEcCtD
Amiodarone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000131	0.000547	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—ovarian cancer	0.000131	0.000546	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00013	0.000544	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—ovarian cancer	0.000129	0.000541	CcSEcCtD
Amiodarone—Anorexia—Docetaxel—ovarian cancer	0.000129	0.000541	CcSEcCtD
Amiodarone—Hepatitis—Epirubicin—ovarian cancer	0.000129	0.000538	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—ovarian cancer	0.000127	0.000532	CcSEcCtD
Amiodarone—Urticaria—Paclitaxel—ovarian cancer	0.000127	0.000532	CcSEcCtD
Amiodarone—Hypotension—Docetaxel—ovarian cancer	0.000127	0.00053	CcSEcCtD
Amiodarone—Abdominal pain—Paclitaxel—ovarian cancer	0.000127	0.000529	CcSEcCtD
Amiodarone—Body temperature increased—Paclitaxel—ovarian cancer	0.000127	0.000529	CcSEcCtD
Amiodarone—Visual impairment—Epirubicin—ovarian cancer	0.000124	0.000519	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—ovarian cancer	0.000124	0.000518	CcSEcCtD
Amiodarone—Insomnia—Docetaxel—ovarian cancer	0.000123	0.000513	CcSEcCtD
Amiodarone—Paraesthesia—Docetaxel—ovarian cancer	0.000122	0.000509	CcSEcCtD
Amiodarone—Erythema multiforme—Epirubicin—ovarian cancer	0.000122	0.000509	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—ovarian cancer	0.000121	0.000507	CcSEcCtD
Amiodarone—Dyspnoea—Docetaxel—ovarian cancer	0.000121	0.000506	CcSEcCtD
Amiodarone—Tinnitus—Epirubicin—ovarian cancer	0.00012	0.000502	CcSEcCtD
Amiodarone—Flushing—Epirubicin—ovarian cancer	0.00012	0.0005	CcSEcCtD
Amiodarone—Dyspepsia—Docetaxel—ovarian cancer	0.000119	0.000499	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—ovarian cancer	0.000119	0.000498	CcSEcCtD
Amiodarone—Decreased appetite—Docetaxel—ovarian cancer	0.000118	0.000493	CcSEcCtD
Amiodarone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000118	0.000493	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000117	0.00049	CcSEcCtD
Amiodarone—Fatigue—Docetaxel—ovarian cancer	0.000117	0.000489	CcSEcCtD
Amiodarone—Constipation—Docetaxel—ovarian cancer	0.000116	0.000485	CcSEcCtD
Amiodarone—Pain—Docetaxel—ovarian cancer	0.000116	0.000485	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—ovarian cancer	0.000115	0.000481	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—ovarian cancer	0.000115	0.00048	CcSEcCtD
Amiodarone—Asthenia—Paclitaxel—ovarian cancer	0.000115	0.00048	CcSEcCtD
Amiodarone—Alopecia—Epirubicin—ovarian cancer	0.000114	0.000476	CcSEcCtD
Amiodarone—Pruritus—Paclitaxel—ovarian cancer	0.000113	0.000473	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—ovarian cancer	0.000113	0.000471	CcSEcCtD
Amiodarone—Erythema—Epirubicin—ovarian cancer	0.000112	0.000469	CcSEcCtD
Amiodarone—Feeling abnormal—Docetaxel—ovarian cancer	0.000112	0.000467	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—ovarian cancer	0.000111	0.000465	CcSEcCtD
Amiodarone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000111	0.000464	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—ovarian cancer	0.000111	0.000462	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—ovarian cancer	0.00011	0.000459	CcSEcCtD
Amiodarone—Diarrhoea—Paclitaxel—ovarian cancer	0.00011	0.000458	CcSEcCtD
Amiodarone—Back pain—Epirubicin—ovarian cancer	0.000108	0.000453	CcSEcCtD
Amiodarone—Abdominal pain—Docetaxel—ovarian cancer	0.000107	0.000448	CcSEcCtD
Amiodarone—Body temperature increased—Docetaxel—ovarian cancer	0.000107	0.000448	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—ovarian cancer	0.000106	0.000445	CcSEcCtD
Amiodarone—Dizziness—Paclitaxel—ovarian cancer	0.000106	0.000443	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—ovarian cancer	0.000106	0.000442	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—ovarian cancer	0.000105	0.00044	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—ovarian cancer	0.000104	0.000435	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—ovarian cancer	0.000104	0.000434	CcSEcCtD
Amiodarone—Agitation—Epirubicin—ovarian cancer	0.000103	0.000431	CcSEcCtD
Amiodarone—Vomiting—Paclitaxel—ovarian cancer	0.000102	0.000425	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—ovarian cancer	0.000102	0.000425	CcSEcCtD
Amiodarone—Malaise—Epirubicin—ovarian cancer	0.000101	0.000423	CcSEcCtD
Amiodarone—Rash—Paclitaxel—ovarian cancer	0.000101	0.000422	CcSEcCtD
Amiodarone—Dermatitis—Paclitaxel—ovarian cancer	0.000101	0.000422	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—ovarian cancer	0.000101	0.000421	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—ovarian cancer	0.0001	0.00042	CcSEcCtD
Amiodarone—Headache—Paclitaxel—ovarian cancer	0.0001	0.000419	CcSEcCtD
Amiodarone—Hypersensitivity—Docetaxel—ovarian cancer	0.0001	0.000418	CcSEcCtD
Amiodarone—Cough—Epirubicin—ovarian cancer	9.79e-05	0.000409	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—ovarian cancer	9.78e-05	0.000409	CcSEcCtD
Amiodarone—Asthenia—Docetaxel—ovarian cancer	9.74e-05	0.000407	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—ovarian cancer	9.63e-05	0.000402	CcSEcCtD
Amiodarone—Pruritus—Docetaxel—ovarian cancer	9.6e-05	0.000401	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—ovarian cancer	9.54e-05	0.000399	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—ovarian cancer	9.52e-05	0.000398	CcSEcCtD
Amiodarone—Nausea—Paclitaxel—ovarian cancer	9.51e-05	0.000397	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—ovarian cancer	9.43e-05	0.000394	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—ovarian cancer	9.36e-05	0.000391	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—ovarian cancer	9.34e-05	0.00039	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—ovarian cancer	9.32e-05	0.00039	CcSEcCtD
Amiodarone—Diarrhoea—Docetaxel—ovarian cancer	9.29e-05	0.000388	CcSEcCtD
Amiodarone—Confusional state—Epirubicin—ovarian cancer	9.23e-05	0.000386	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—ovarian cancer	9.15e-05	0.000383	CcSEcCtD
Amiodarone—Oedema—Epirubicin—ovarian cancer	9.15e-05	0.000383	CcSEcCtD
Amiodarone—Infection—Epirubicin—ovarian cancer	9.09e-05	0.00038	CcSEcCtD
Amiodarone—Cough—Doxorubicin—ovarian cancer	9.06e-05	0.000378	CcSEcCtD
Amiodarone—Shock—Epirubicin—ovarian cancer	9.01e-05	0.000376	CcSEcCtD
Amiodarone—Dizziness—Docetaxel—ovarian cancer	8.97e-05	0.000375	CcSEcCtD
Amiodarone—Thrombocytopenia—Epirubicin—ovarian cancer	8.96e-05	0.000375	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—ovarian cancer	8.93e-05	0.000373	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—ovarian cancer	8.89e-05	0.000372	CcSEcCtD
Amiodarone—Hyperhidrosis—Epirubicin—ovarian cancer	8.85e-05	0.00037	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—ovarian cancer	8.8e-05	0.000368	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—ovarian cancer	8.73e-05	0.000365	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—ovarian cancer	8.73e-05	0.000365	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—ovarian cancer	8.64e-05	0.000361	CcSEcCtD
Amiodarone—Vomiting—Docetaxel—ovarian cancer	8.63e-05	0.000361	CcSEcCtD
Amiodarone—Rash—Docetaxel—ovarian cancer	8.56e-05	0.000358	CcSEcCtD
Amiodarone—Hypotension—Epirubicin—ovarian cancer	8.55e-05	0.000357	CcSEcCtD
Amiodarone—Dermatitis—Docetaxel—ovarian cancer	8.55e-05	0.000357	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—ovarian cancer	8.54e-05	0.000357	CcSEcCtD
Amiodarone—Headache—Docetaxel—ovarian cancer	8.5e-05	0.000355	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—ovarian cancer	8.47e-05	0.000354	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—ovarian cancer	8.47e-05	0.000354	CcSEcCtD
Amiodarone—Infection—Doxorubicin—ovarian cancer	8.41e-05	0.000352	CcSEcCtD
Amiodarone—Shock—Doxorubicin—ovarian cancer	8.33e-05	0.000348	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—ovarian cancer	8.29e-05	0.000347	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—ovarian cancer	8.28e-05	0.000346	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—ovarian cancer	8.27e-05	0.000345	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—ovarian cancer	8.23e-05	0.000344	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—ovarian cancer	8.22e-05	0.000344	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—ovarian cancer	8.19e-05	0.000342	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—ovarian cancer	8.16e-05	0.000341	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—ovarian cancer	8.07e-05	0.000337	CcSEcCtD
Amiodarone—Nausea—Docetaxel—ovarian cancer	8.06e-05	0.000337	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—ovarian cancer	8.06e-05	0.000337	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—ovarian cancer	7.96e-05	0.000333	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—ovarian cancer	7.91e-05	0.000331	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—ovarian cancer	7.9e-05	0.00033	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—ovarian cancer	7.89e-05	0.00033	CcSEcCtD
Amiodarone—Pain—Epirubicin—ovarian cancer	7.83e-05	0.000327	CcSEcCtD
Amiodarone—Constipation—Epirubicin—ovarian cancer	7.83e-05	0.000327	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—ovarian cancer	7.66e-05	0.00032	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—ovarian cancer	7.61e-05	0.000318	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—ovarian cancer	7.55e-05	0.000316	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—ovarian cancer	7.54e-05	0.000315	CcSEcCtD
Amiodarone—Gastrointestinal pain—Epirubicin—ovarian cancer	7.48e-05	0.000313	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—ovarian cancer	7.46e-05	0.000312	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—ovarian cancer	7.36e-05	0.000308	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	7.31e-05	0.000306	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—ovarian cancer	7.3e-05	0.000305	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—ovarian cancer	7.27e-05	0.000304	CcSEcCtD
Amiodarone—Pain—Doxorubicin—ovarian cancer	7.24e-05	0.000303	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—ovarian cancer	7.24e-05	0.000303	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—ovarian cancer	7.24e-05	0.000302	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—ovarian cancer	7.24e-05	0.000302	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—ovarian cancer	6.98e-05	0.000292	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—ovarian cancer	6.93e-05	0.000289	CcSEcCtD
Amiodarone—Hypersensitivity—Epirubicin—ovarian cancer	6.74e-05	0.000282	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—ovarian cancer	6.73e-05	0.000281	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—ovarian cancer	6.7e-05	0.00028	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—ovarian cancer	6.7e-05	0.00028	CcSEcCtD
Amiodarone—Asthenia—Epirubicin—ovarian cancer	6.57e-05	0.000274	CcSEcCtD
Amiodarone—Pruritus—Epirubicin—ovarian cancer	6.48e-05	0.000271	CcSEcCtD
Amiodarone—Diarrhoea—Epirubicin—ovarian cancer	6.26e-05	0.000262	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—ovarian cancer	6.24e-05	0.000261	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—ovarian cancer	6.08e-05	0.000254	CcSEcCtD
Amiodarone—Dizziness—Epirubicin—ovarian cancer	6.05e-05	0.000253	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—ovarian cancer	5.99e-05	0.00025	CcSEcCtD
Amiodarone—Vomiting—Epirubicin—ovarian cancer	5.82e-05	0.000243	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—ovarian cancer	5.79e-05	0.000242	CcSEcCtD
Amiodarone—Rash—Epirubicin—ovarian cancer	5.77e-05	0.000241	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—ovarian cancer	5.77e-05	0.000241	CcSEcCtD
Amiodarone—Headache—Epirubicin—ovarian cancer	5.73e-05	0.00024	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—ovarian cancer	5.6e-05	0.000234	CcSEcCtD
Amiodarone—Nausea—Epirubicin—ovarian cancer	5.44e-05	0.000227	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—ovarian cancer	5.38e-05	0.000225	CcSEcCtD
Amiodarone—Rash—Doxorubicin—ovarian cancer	5.34e-05	0.000223	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—ovarian cancer	5.34e-05	0.000223	CcSEcCtD
Amiodarone—Headache—Doxorubicin—ovarian cancer	5.31e-05	0.000222	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—ovarian cancer	5.03e-05	0.00021	CcSEcCtD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.44e-05	0.000218	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.44e-05	0.000218	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—YAP1—ovarian cancer	1.42e-05	0.000214	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6ST—ovarian cancer	1.41e-05	0.000214	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP1B1—ovarian cancer	1.41e-05	0.000214	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.41e-05	0.000214	CbGpPWpGaD
Amiodarone—EBP—Metabolism—AKT1—ovarian cancer	1.4e-05	0.000212	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.4e-05	0.000212	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1.37e-05	0.000207	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.36e-05	0.000206	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CG—ovarian cancer	1.36e-05	0.000206	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.35e-05	0.000204	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.35e-05	0.000204	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CD—ovarian cancer	1.31e-05	0.000199	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—YAP1—ovarian cancer	1.3e-05	0.000197	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.29e-05	0.000195	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ABCB1—ovarian cancer	1.27e-05	0.000192	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.26e-05	0.000191	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.25e-05	0.00019	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	1.25e-05	0.00019	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—TYMS—ovarian cancer	1.25e-05	0.000189	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.23e-05	0.000187	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PIK3CA—ovarian cancer	1.22e-05	0.000185	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—FASN—ovarian cancer	1.22e-05	0.000185	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.21e-05	0.000183	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.2e-05	0.000182	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PPP2R1A—ovarian cancer	1.2e-05	0.000181	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CD—ovarian cancer	1.19e-05	0.000181	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYTB—ovarian cancer	1.19e-05	0.00018	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ABCB1—ovarian cancer	1.16e-05	0.000176	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.16e-05	0.000176	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—YAP1—ovarian cancer	1.16e-05	0.000175	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—FASN—ovarian cancer	1.16e-05	0.000175	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.15e-05	0.000174	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.15e-05	0.000174	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CB—ovarian cancer	1.15e-05	0.000173	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—TYMS—ovarian cancer	1.14e-05	0.000173	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SLC5A5—ovarian cancer	1.14e-05	0.000172	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—YAP1—ovarian cancer	1.13e-05	0.000171	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.13e-05	0.000171	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.11e-05	0.000169	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCL8—ovarian cancer	1.1e-05	0.000167	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SLC2A1—ovarian cancer	1.1e-05	0.000166	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.07e-05	0.000163	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—YAP1—ovarian cancer	1.07e-05	0.000161	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—FASN—ovarian cancer	1.06e-05	0.00016	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—YAP1—ovarian cancer	1.06e-05	0.00016	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—IL2—ovarian cancer	1.05e-05	0.000159	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CYP1B1—ovarian cancer	1.05e-05	0.000159	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.05e-05	0.000158	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.04e-05	0.000158	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CB—ovarian cancer	1.04e-05	0.000157	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.04e-05	0.000157	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.04e-05	0.000157	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.02e-05	0.000155	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.01e-05	0.000153	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.01e-05	0.000152	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CAV1—ovarian cancer	1e-05	0.000152	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCL8—ovarian cancer	1e-05	0.000151	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—AKT1—ovarian cancer	9.99e-06	0.000151	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	9.88e-06	0.000149	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.85e-06	0.000149	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.82e-06	0.000149	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP1B1—ovarian cancer	9.65e-06	0.000146	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL2—ovarian cancer	9.56e-06	0.000145	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TERT—ovarian cancer	9.52e-06	0.000144	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—FASN—ovarian cancer	9.45e-06	0.000143	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	9.33e-06	0.000141	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SLC5A5—ovarian cancer	9.3e-06	0.000141	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.28e-06	0.000141	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—FASN—ovarian cancer	9.23e-06	0.00014	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CAV1—ovarian cancer	9.2e-06	0.000139	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.2e-06	0.000139	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ABCB1—ovarian cancer	9.17e-06	0.000139	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CG—ovarian cancer	9.14e-06	0.000138	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SLC5A5—ovarian cancer	9.07e-06	0.000137	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—YAP1—ovarian cancer	9.03e-06	0.000137	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TYMS—ovarian cancer	9.01e-06	0.000136	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SLC2A1—ovarian cancer	8.98e-06	0.000136	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.94e-06	0.000135	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CAV1—ovarian cancer	8.81e-06	0.000133	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.79e-06	0.000133	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SLC2A1—ovarian cancer	8.76e-06	0.000133	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—FASN—ovarian cancer	8.69e-06	0.000132	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ABCB1—ovarian cancer	8.66e-06	0.000131	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—FASN—ovarian cancer	8.62e-06	0.00013	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP1B1—ovarian cancer	8.61e-06	0.00013	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	8.55e-06	0.000129	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SLC5A5—ovarian cancer	8.55e-06	0.000129	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.51e-06	0.000129	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TYMS—ovarian cancer	8.51e-06	0.000129	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ESR1—ovarian cancer	8.49e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SLC5A5—ovarian cancer	8.48e-06	0.000128	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP1B1—ovarian cancer	8.4e-06	0.000127	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CG—ovarian cancer	8.38e-06	0.000127	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6ST—ovarian cancer	8.35e-06	0.000126	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SLC2A1—ovarian cancer	8.26e-06	0.000125	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SLC2A1—ovarian cancer	8.19e-06	0.000124	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CD—ovarian cancer	8.04e-06	0.000122	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APC—ovarian cancer	8.02e-06	0.000121	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CG—ovarian cancer	8.02e-06	0.000121	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—NRAS—ovarian cancer	8.02e-06	0.000121	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.02e-06	0.000121	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ABCB1—ovarian cancer	7.94e-06	0.00012	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP1B1—ovarian cancer	7.92e-06	0.00012	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.86e-06	0.000119	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP1B1—ovarian cancer	7.85e-06	0.000119	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TYMS—ovarian cancer	7.8e-06	0.000118	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—MAPK3—ovarian cancer	7.68e-06	0.000116	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	7.64e-06	0.000116	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.6e-06	0.000115	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPP2R1A—ovarian cancer	7.45e-06	0.000113	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CD—ovarian cancer	7.37e-06	0.000112	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—FASN—ovarian cancer	7.37e-06	0.000111	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—MAPK1—ovarian cancer	7.31e-06	0.000111	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—ovarian cancer	7.31e-06	0.000111	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CAV1—ovarian cancer	7.26e-06	0.00011	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC5A5—ovarian cancer	7.24e-06	0.00011	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ABCB1—ovarian cancer	7.09e-06	0.000107	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CD—ovarian cancer	7.05e-06	0.000107	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	7.02e-06	0.000106	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CB—ovarian cancer	7.01e-06	0.000106	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC2A1—ovarian cancer	7e-06	0.000106	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—ovarian cancer	6.99e-06	0.000106	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—YAP1—ovarian cancer	6.97e-06	0.000106	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TYMS—ovarian cancer	6.96e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	6.96e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.93e-06	0.000105	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—ovarian cancer	6.91e-06	0.000104	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CAV1—ovarian cancer	6.86e-06	0.000104	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.85e-06	0.000104	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TYMS—ovarian cancer	6.8e-06	0.000103	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP1B1—ovarian cancer	6.71e-06	0.000102	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CG—ovarian cancer	6.61e-06	0.0001	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.55e-06	9.91e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ABCB1—ovarian cancer	6.52e-06	9.87e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ABCB1—ovarian cancer	6.46e-06	9.78e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CB—ovarian cancer	6.42e-06	9.72e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TYMS—ovarian cancer	6.4e-06	9.69e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TYMS—ovarian cancer	6.35e-06	9.61e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—ovarian cancer	6.34e-06	9.6e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CAV1—ovarian cancer	6.29e-06	9.51e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CG—ovarian cancer	6.25e-06	9.45e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—ovarian cancer	6.23e-06	9.43e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MTOR—ovarian cancer	6.15e-06	9.3e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CB—ovarian cancer	6.15e-06	9.3e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—ovarian cancer	6.05e-06	9.16e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.01e-06	9.09e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	5.95e-06	9e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.92e-06	8.96e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—ovarian cancer	5.91e-06	8.94e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—ovarian cancer	5.87e-06	8.88e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CD—ovarian cancer	5.81e-06	8.79e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1B—ovarian cancer	5.77e-06	8.73e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CG—ovarian cancer	5.73e-06	8.66e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—ovarian cancer	5.71e-06	8.64e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—FASN—ovarian cancer	5.68e-06	8.6e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—ovarian cancer	5.65e-06	8.56e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2—ovarian cancer	5.65e-06	8.54e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6—ovarian cancer	5.62e-06	8.5e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CAV1—ovarian cancer	5.61e-06	8.49e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.59e-06	8.46e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—ovarian cancer	5.55e-06	8.4e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ABCB1—ovarian cancer	5.52e-06	8.36e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—ovarian cancer	5.5e-06	8.33e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CD—ovarian cancer	5.49e-06	8.31e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CAV1—ovarian cancer	5.48e-06	8.29e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CTNNB1—ovarian cancer	5.45e-06	8.25e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TYMS—ovarian cancer	5.43e-06	8.21e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.4e-06	8.17e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.36e-06	8.11e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—ovarian cancer	5.34e-06	8.09e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—ovarian cancer	5.31e-06	8.04e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—ovarian cancer	5.18e-06	7.84e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.18e-06	7.83e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CAV1—ovarian cancer	5.16e-06	7.81e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CAV1—ovarian cancer	5.12e-06	7.74e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CG—ovarian cancer	5.11e-06	7.73e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CB—ovarian cancer	5.07e-06	7.67e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CD—ovarian cancer	5.03e-06	7.62e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.99e-06	7.55e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.89e-06	7.4e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—ovarian cancer	4.8e-06	7.26e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CB—ovarian cancer	4.79e-06	7.24e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—ovarian cancer	4.75e-06	7.19e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NRAS—ovarian cancer	4.74e-06	7.17e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CG—ovarian cancer	4.7e-06	7.11e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CG—ovarian cancer	4.66e-06	7.05e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.59e-06	6.95e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK3—ovarian cancer	4.54e-06	6.87e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CD—ovarian cancer	4.49e-06	6.8e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—ovarian cancer	4.41e-06	6.68e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CB—ovarian cancer	4.39e-06	6.64e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.38e-06	6.64e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—ovarian cancer	4.38e-06	6.62e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CAV1—ovarian cancer	4.37e-06	6.62e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK1—ovarian cancer	4.32e-06	6.54e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—ovarian cancer	4.32e-06	6.53e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—ovarian cancer	4.27e-06	6.46e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.26e-06	6.45e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TYMS—ovarian cancer	4.19e-06	6.34e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.18e-06	6.32e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—ovarian cancer	4.14e-06	6.26e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CD—ovarian cancer	4.13e-06	6.25e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.1e-06	6.2e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—ovarian cancer	4.08e-06	6.17e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CG—ovarian cancer	3.98e-06	6.03e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CB—ovarian cancer	3.92e-06	5.93e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—ovarian cancer	3.92e-06	5.93e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.82e-06	5.78e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—ovarian cancer	3.79e-06	5.74e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—ovarian cancer	3.75e-06	5.67e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—ovarian cancer	3.63e-06	5.49e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CB—ovarian cancer	3.6e-06	5.45e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.57e-06	5.4e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CD—ovarian cancer	3.5e-06	5.3e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—ovarian cancer	3.49e-06	5.28e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—ovarian cancer	3.47e-06	5.25e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—ovarian cancer	3.38e-06	5.12e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CAV1—ovarian cancer	3.37e-06	5.11e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6—ovarian cancer	3.32e-06	5.02e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—ovarian cancer	3.3e-06	5e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—ovarian cancer	3.2e-06	4.84e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—ovarian cancer	3.11e-06	4.71e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.09e-06	4.67e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—ovarian cancer	3.09e-06	4.67e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.07e-06	4.65e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—ovarian cancer	3.06e-06	4.63e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.05e-06	4.62e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—ovarian cancer	2.92e-06	4.41e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.7e-06	4.09e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.67e-06	4.05e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—ovarian cancer	2.64e-06	3.99e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—ovarian cancer	2.52e-06	3.82e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.39e-06	3.61e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—ovarian cancer	2.38e-06	3.61e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.35e-06	3.56e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.33e-06	3.53e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.2e-06	3.32e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—ovarian cancer	2.18e-06	3.31e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.18e-06	3.29e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—ovarian cancer	2.03e-06	3.08e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—ovarian cancer	1.95e-06	2.95e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—ovarian cancer	1.9e-06	2.88e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.86e-06	2.81e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—ovarian cancer	1.79e-06	2.71e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—ovarian cancer	1.78e-06	2.69e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—ovarian cancer	1.52e-06	2.3e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.44e-06	2.17e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—ovarian cancer	1.17e-06	1.77e-05	CbGpPWpGaD
